Hot Pursuit     09-Jun-23
Biocon's Bangalore-based API facility gets GMP certificate from German authority
Biocon said that its active pharmaceutical ingredient (API) manufacturing facility located in Bangalore has received a certificate of GMP compliance from the Competent Authority of Germany.

The said GMP compliance certificate has been issued post the EU GMP inspection that was conducted in February 2023 at the company's aforementioned facility.

Biocon is an innovation-led global biopharmaceuticals company. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US, Europe & key emerging markets.

The company reported 31% rise in consolidated net profit to Rs 313 crore on a 57% increase in revenue from operations to Rs 3,774 crore in Q4 FY23 as compared with Q4 FY22. Consolidated total revenue for Q4 FY23 increased 59% year-on-year (YoY) to Rs 3,929 crore.

The scrip rose 0.75% to currently trade at Rs 243.30 on the BSE.

Previous News
  Market at day’s high; VIX climbs 3.96%; realty shares advance
 ( Market Commentary - Mid-Session 18-Apr-24   12:37 )
  Biocon receives Complete Response Letter for Biologics License Application
 ( Corporate News - 09-Feb-24   09:11 )
  Biocon jumps after inking pact with Biomm SA
 ( Hot Pursuit - 18-Apr-24   11:47 )
  Biocon Ltd soars 2.25%, up for fifth straight session
 ( Hot Pursuit - 11-Jun-24   13:00 )
  Biocon consolidated net profit rises 31.27% in the March 2023 quarter
 ( Results - Announcements 24-May-23   07:33 )
  Biocon consolidated net profit rises 167.80% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   17:28 )
  Biocon edges higher after obtaining UK MHRA nod for diabetes drug Liraglutide
 ( Hot Pursuit - 28-Mar-24   10:06 )
  Biocon Biologics partners with Sandoz AG
 ( Corporate News - 09-Feb-24   09:15 )
  Indices edge lower, Nifty near 18,300; breadth positive
 ( Market Commentary - Mid-Session 24-May-23   09:32 )
  Biocon to declare Quarterly Result
 ( Corporate News - 10-Oct-23   11:29 )
  Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
 ( Corporate News - 09-Nov-23   09:15 )
Other Stories
  DCB Bank rises on appointing Mahesh Raman as CRO
  12-Jun-24   15:07
  Va Tech Wabag Ltd leads losers in 'A' group
  12-Jun-24   15:00
  Brigade Ent plans to invest Rs 8000 cr in Chennai by 2030
  12-Jun-24   14:54
  Indian Metals & Ferro Alloys Ltd leads losers in 'B' group
  12-Jun-24   14:45
  Volumes soar at Elecon Engineering Company Ltd counter
  12-Jun-24   14:30
  BSE SME Magenta Lifecare jumps on debut
  12-Jun-24   14:22
  BSE SME 3C IT Solutions & Telecoms (India) drops on listing day
  12-Jun-24   14:18
  FMCG shares fall
  12-Jun-24   14:00
  Real Estate shares fall
  12-Jun-24   14:00
  Bhandari Hosiery zooms on fixing record date for rights issue
  12-Jun-24   13:19
Back Top